BACKGROUND: We have previously shown that several metabolic genes are downregulated in the failing human heart. We now tested the hypothesis that mechanical unloading might reverse this process. METHODS: Clinical data and myocardial tissue were collected from 14 failing hearts paired for the time of implantation and explantation of a left ventricular assist device (LVAD) and compared to 10 non-failing hearts. Transcript levels for key regulators of energy metabolism and for atrial natriuretic factor (ANF) were measured by real-time quantitative RT-PCR. RESULTS: The expression of the glucose transporter 1 and 4 (GLUT1, GLUT4), muscle carnitine palmitoyl transferase-1 (mCPT-1), and uncoupling protein 3 (UCP3) were downregulated by up to 80% in the failing heart. Although LVAD treatment improved clinical markers of heart failure (decrease of left ventricular diastolic dimension and normalization of serum sodium), only UCP3 expression reversed to non-failing transcript levels following mechanical unloading. CONCLUSIONS: LVAD treatment only partially reverses depressed metabolic gene expression in the failing human heart. Reversal of depressed UCP3 expression may be an important mechanism for reducing the formation of oxygen-derived free radicals. Further studies are necessary to define the effects of mechanical unloading on post-transcriptional mechanisms. Copyright 2002 S. Karger AG, Basel
BACKGROUND: We have previously shown that several metabolic genes are downregulated in the failing human heart. We now tested the hypothesis that mechanical unloading might reverse this process. METHODS: Clinical data and myocardial tissue were collected from 14 failing hearts paired for the time of implantation and explantation of a left ventricular assist device (LVAD) and compared to 10 non-failing hearts. Transcript levels for key regulators of energy metabolism and for atrial natriuretic factor (ANF) were measured by real-time quantitative RT-PCR. RESULTS: The expression of the glucose transporter 1 and 4 (GLUT1, GLUT4), muscle carnitine palmitoyl transferase-1 (mCPT-1), and uncoupling protein 3 (UCP3) were downregulated by up to 80% in the failing heart. Although LVAD treatment improved clinical markers of heart failure (decrease of left ventricular diastolic dimension and normalization of serum sodium), only UCP3 expression reversed to non-failing transcript levels following mechanical unloading. CONCLUSIONS:LVAD treatment only partially reverses depressed metabolic gene expression in the failing human heart. Reversal of depressed UCP3 expression may be an important mechanism for reducing the formation of oxygen-derived free radicals. Further studies are necessary to define the effects of mechanical unloading on post-transcriptional mechanisms. Copyright 2002 S. Karger AG, Basel
Authors: Khaled Qanud; Mohammed Mamdani; Martino Pepe; Ramzi J Khairallah; John Gravel; Biao Lei; Sachin A Gupte; Victor G Sharov; Hani N Sabbah; William C Stanley; Fabio A Recchia Journal: Am J Physiol Heart Circ Physiol Date: 2008-09-26 Impact factor: 4.733
Authors: Julian Mustroph; Charlotte M Lücht; Olivia Wagemann; Thomas Sowa; Karin P Hammer; Can M Sag; Daniel Tarnowski; Andreas Holzamer; Steffen Pabel; Bo Eric Beuthner; Samuel Sossalla; Lars S Maier; Stefan Wagner Journal: Diabetologia Date: 2019-04 Impact factor: 10.122
Authors: Renata O Pereira; Adam R Wende; Curtis Olsen; Jamie Soto; Tenley Rawlings; Yi Zhu; Christian Riehle; E Dale Abel Journal: J Mol Cell Cardiol Date: 2014-02-25 Impact factor: 5.000
Authors: Marcello Panagia; Huamei He; Tomas Baka; David R Pimentel; Dominique Croteau; Markus M Bachschmid; James A Balschi; Wilson S Colucci; Ivan Luptak Journal: NMR Biomed Date: 2020-02-17 Impact factor: 4.044
Authors: Cevher Ozcan; Monica Palmeri; Tamas L Horvath; Kerry S Russell; Raymond R Russell Journal: Am J Physiol Heart Circ Physiol Date: 2013-03-01 Impact factor: 4.733